| Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
|---|
| D000521 |
alpha-MSH |
alpha-MSH binds to and results in increased activity of CARTPT protein | affects binding|increases activity | 15659233
|
| D015081 |
2-Naphthylamine |
2-Naphthylamine results in increased expression of CARTPT mRNA | increases expression | 18247414
|
| D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of CARTPT mRNA | affects expression | 16483693
|
| D000661 |
Amphetamine |
Amphetamine results in increased expression of CARTPT mRNA | increases expression | 16896163
|
| C120841 |
astressin B |
astressin B inhibits the reaction [CARTPT protein results in increased abundance of Corticosterone] | decreases reaction|increases abundance | 15271883
|
| C120841 |
astressin B |
astressin B inhibits the reaction [CARTPT protein results in increased secretion of POMC protein alternative form] | decreases reaction|increases secretion | 15271883
|
| D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in increased expression of CARTPT mRNA | increases expression | 18247414
|
| C070515 |
bisindolylmaleimide I |
bisindolylmaleimide I inhibits the reaction [CARTPT protein results in increased phosphorylation of GRIN1 protein] | decreases reaction|increases phosphorylation | 19632277
|
| D002713 |
Chlorine |
Chlorine results in decreased expression of CARTPT mRNA | decreases expression | 18636392
|
| D002713 |
Chlorine |
[Ozone co-treated with Chlorine] affects the expression of CARTPT mRNA | affects cotreatment|affects expression | 18636392
|
| D003024 |
Clozapine |
Clozapine results in decreased expression of CARTPT mRNA | decreases expression | 14696011
|
| D003345 |
Corticosterone |
astressin B inhibits the reaction [CARTPT protein results in increased abundance of Corticosterone] | decreases reaction|increases abundance | 15271883
|
| D003345 |
Corticosterone |
CARTPT protein results in increased abundance of Corticosterone | increases abundance | 15271883
|
| D015102 |
3,4-Dihydroxyphenylacetic Acid |
CARTPT protein results in increased abundance of 3,4-Dihydroxyphenylacetic Acid | increases abundance | 15659233
|
| D004958 |
Estradiol |
Estradiol results in increased expression of CARTPT mRNA | increases expression | 20068009
|
| C056599 |
icariin |
icariin results in increased expression of CARTPT mRNA | increases expression | 19858766
|
| C056599 |
icariin |
icariin results in increased expression of CARTPT protein | increases expression | 19858766
|
| C057416 |
KT 5720 |
KT 5720 inhibits the reaction [CARTPT protein results in increased phosphorylation of GRIN1 protein] | decreases reaction|increases phosphorylation | 19632277
|
| D008070 |
Lipopolysaccharides |
Lipopolysaccharides affects the localization of CARTPT protein | affects localization | 12559087
|
| D008070 |
Lipopolysaccharides |
Lipopolysaccharides results in increased expression of CARTPT protein | increases expression | 12559087
|
| D009020 |
Morphine |
Morphine results in increased expression of CARTPT mRNA | increases expression | 20144693
|
| D009538 |
Nicotine |
Nicotine results in decreased expression of CARTPT mRNA | decreases expression | 18247414
|
| D010126 |
Ozone |
[Ozone co-treated with Chlorine] affects the expression of CARTPT mRNA | affects cotreatment|affects expression | 18636392
|
| D012402 |
Rotenone |
Rotenone results in decreased expression of CARTPT mRNA | decreases expression | 19013527
|
| D013311 |
Streptozocin |
GHRL protein promotes the reaction [Streptozocin results in decreased expression of CARTPT mRNA] | decreases expression|increases reaction | 20219977
|
| D013311 |
Streptozocin |
Streptozocin results in decreased expression of CARTPT mRNA | decreases expression | 20219977
|
| D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with LEP protein] affects the expression of CARTPT mRNA | affects cotreatment|affects expression | 15977195
|
| D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of CARTPT mRNA | increases expression | 15093705
|
| Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
|---|
| MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
2.74 | 15322242 14514962 11752688 |
| MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.45 | 18287403 |
| MESH:D055371 |
Acute Lung Injury |
|
Chlorine |
9.14 | 20601635 |
| MESH:D055371 |
Acute Lung Injury |
|
Lipopolysaccharides |
9.14 | 11850527 18653653 |
| MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
4.19 | 20127859 20464547 |
| MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
4.19 | 11473722 |
| MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
2.59 | 6695378 |
| MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.27 | 16835633 |
| MESH:D000380 |
Agranulocytosis |
|
Clozapine |
4.95 | 12649775 14617031 16160616 |
| MESH:D000505 |
Alopecia |
|
astressin B |
5.80 | 21359208 |
| MESH:D000544 |
Alzheimer Disease |
|
icariin |
6.84 | 19858766 19782061 |
| MESH:D000544 |
Alzheimer Disease |
|
Nicotine |
6.84 | 16627626 |
| MESH:D000544 |
Alzheimer Disease |
|
Ozone |
6.84 | 15513908 |
| MESH:D019969 |
Amphetamine-Related Disorders |
|
Amphetamine |
5.95 | 18475255 15010207 16459022 16916582 |
| MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.85 | 11748828 |
| MESH:D000855 |
Anorexia |
|
Amphetamine |
4.91 | 12005258 16084549 12183048 16101753 |
| MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
3.96 | 19183758 |
| MESH:D001172 |
Arthritis, Rheumatoid |
|
Ozone |
2.53 | 15570426 |
| MESH:D001249 |
Asthma |
|
Ozone |
2.60 | 16373670 17854713 |
| MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
2.94 | 12125929 |
| MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.69 | 15340226 |
| MESH:D001847 |
Bone Diseases |
|
icariin |
6.30 | 18295595 |
| MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.69 | 15746008 |
| MESH:D002545 |
Brain Ischemia |
|
icariin |
10.70 | 19303870 |
| MESH:D002545 |
Brain Ischemia |
|
Morphine |
10.70 | 19211983 |
| MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
1.79 | 17474063 20146248 |
| MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
1.79 | 17261762 12948864 16675129 19861407 14630087 18497071 17289903 17018787 |
| MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.79 | 20435547 |
| MESH:D016535 |
Bronchial Hyperreactivity |
|
Ozone |
3.59 | 18417511 16777450 18315731 17626835 15516495 19059883 14754758 |
| MESH:D002100 |
Cachexia |
|
Ozone |
4.63 | 16183385 |
| MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.35 | 16111702 |
| MESH:D002276 |
Carcinoid Tumor |
|
Streptozocin |
5.50 | 16051944 |
| MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.71 | 16835633 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
1.75 | 16924424 |
| MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
2.02 | 20419170 |
| MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.31 | 18850075 18670907 16120746 |
| MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
2.70 | 18566989 |
| MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.07 | 16835633 |
| MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.06 | 15668235 8697196 16354765 12621046 15340226 |
| MESH:D003072 |
Cognition Disorders |
|
Clozapine |
4.85 | 17123785 |
| MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.96 | 17141729 14669216 |
| MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.25 | 20055451 15322242 10048152 |
| MESH:D003920 |
Diabetes Mellitus |
|
Streptozocin |
4.63 | 16285004 |
| MESH:D003921 |
Diabetes Mellitus, Experimental |
|
Streptozocin |
4.39 | 19496084 16286809 11055810 7637645 2177838 16684804 18603373 15298345 12446591 17442507 15862027 18715473 8740154 12093613 11260395 12083368 12644472 17874149 15831366 1374869 19960420 19298542 19586609 6379147 |
| MESH:D003922 |
Diabetes Mellitus, Type 1 |
|
Streptozocin |
3.60 | 18603373 |
| MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Clozapine |
7.17 | 16402076 |
| MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Streptozocin |
7.17 | 19647726 19586609 |
| MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
7.17 | 17107852 |
| MESH:D058065 |
Diabetic Cardiomyopathies |
|
Streptozocin |
5.62 | 16025228 |
| MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
8.96 | 19279558 |
| MESH:D003928 |
Diabetic Nephropathies |
|
Streptozocin |
8.96 | 19682444 19960420 |
| MESH:D003930 |
Diabetic Retinopathy |
|
Streptozocin |
5.32 | 17662242 |
| MESH:D003967 |
Diarrhea |
|
Morphine |
4.41 | 2540324 |
| MESH:D006970 |
Disorders of Excessive Somnolence |
|
Clozapine |
5.45 | 15331141 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
1.51 | 20420201 |
| MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.68 | 11462148 |
| MESH:D050171 |
Dyslipidemias |
|
Clozapine |
4.10 | 16402076 |
| MESH:D004417 |
Dyspnea |
|
Chlorine |
4.52 | 20016425 |
| MESH:D020821 |
Dystonic Disorders |
|
Nicotine |
5.82 | 17881519 |
| MESH:D004487 |
Edema |
|
bisindolylmaleimide I |
6.91 | 8273558 |
| MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
6.91 | 11000095 12711302 |
| MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.80 | 16714409 15322242 18230668 |
| MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
2.91 | 18566989 19148513 11473722 |
| MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
2.92 | 10568697 9294722 |
| MESH:D019446 |
Endotoxemia |
|
Lipopolysaccharides |
4.29 | 15328337 17637181 15821434 |
| MESH:D007172 |
Erectile Dysfunction |
|
icariin |
5.32 | 16281085 15329286 |
| MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
1.98 | 16530937 |
| MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
2.93 | 11564622 |
| MESH:D005221 |
Fatigue |
|
Amphetamine |
5.49 | 19890266 |
| MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.35 | 11858732 |
| MESH:D005334 |
Fever |
|
Lipopolysaccharides |
3.91 | 11852909 9205823 |
| MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
2.84 | 20067830 |
| MESH:D005739 |
Gas Poisoning |
|
Chlorine |
4.90 | 20016425 |
| MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.49 | 10696789 |
| MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
6.26 | 20471113 |
| MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
6.26 | 11294989 10048152 |
| MESH:D006331 |
Heart Diseases |
|
Streptozocin |
4.20 | 12093613 |
| MESH:D006463 |
Hemolytic-Uremic Syndrome |
|
Lipopolysaccharides |
4.28 | 16366002 |
| MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.23 | 11000095 |
| MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
2.78 | 16120746 15340226 12621046 |
| MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
4.93 | 15709030 |
| MESH:D019584 |
Hot Flashes |
|
Estradiol |
3.65 | 17088409 |
| MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.94 | 16354765 18606429 8697196 15340226 16959395 |
| MESH:D006948 |
Hyperkinesis |
|
Amphetamine |
11.44 | 1977408 14960337 |
| MESH:D006948 |
Hyperkinesis |
|
Clozapine |
11.44 | 16046005 |
| MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.87 | 18850075 18670907 |
| MESH:D006980 |
Hyperthyroidism |
marker/mechanism |
|
| 12395121 |
| MESH:D007249 |
Inflammation |
|
bisindolylmaleimide I |
8.21 | 8273558 |
| MESH:D007249 |
Inflammation |
|
Lipopolysaccharides |
8.21 | 9205823 17237260 12878042 17255318 17963957 |
| MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
8.21 | 12878042 12200463 |
| MESH:D007333 |
Insulin Resistance |
|
Estradiol |
2.89 | 16627594 16393666 |
| MESH:D019189 |
Iron Metabolism Disorders |
|
Lipopolysaccharides |
4.53 | 17255318 |
| MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.23 | 16580747 |
| MESH:D007674 |
Kidney Diseases |
|
Estradiol |
6.28 | 15618244 |
| MESH:D007674 |
Kidney Diseases |
|
Streptozocin |
6.28 | 12093613 |
| MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
2.89 | 15610895 |
| MESH:D007859 |
Learning Disorders |
|
icariin |
5.21 | 19782061 |
| MESH:D007970 |
Leukopenia |
|
Lipopolysaccharides |
4.59 | 15821434 |
| MESH:D008064 |
Lipidoses |
|
Clozapine |
3.88 | 17567588 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
3.43 | 14716833 14659978 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Lipopolysaccharides |
3.43 | 12878042 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
3.43 | 12878042 |
| MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
4.19 | 21137059 20195826 |
| MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
4.19 | 16984957 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
2.04 | 12151625 |
| MESH:D008171 |
Lung Diseases |
|
Ozone |
3.30 | 19066396 8266340 |
| MESH:D055370 |
Lung Injury |
|
Lipopolysaccharides |
8.88 | 21114838 |
| MESH:D055370 |
Lung Injury |
|
Ozone |
8.88 | 20417186 |
| MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
3.32 | 20464547 20064080 18520028 18816296 17053015 20135361 18569708 20869020 6695378 |
| MESH:D008175 |
Lung Neoplasms |
|
Ozone |
3.32 | 8597069 7614698 |
| MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
3.32 | 19555203 11884234 |
| MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Corticosterone |
6.10 | 12807724 |
| MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
6.10 | 11408345 11807958 17203775 16891317 |
| MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
4.38 | 19453300 |
| MESH:D008569 |
Memory Disorders |
|
icariin |
5.19 | 19782061 |
| MESH:D001523 |
Mental Disorders |
|
Clozapine |
3.84 | 16856516 |
| MESH:D024821 |
Metabolic Syndrome X |
|
Clozapine |
4.32 | 19142101 |
| MESH:D008679 |
Metaplasia |
|
Ozone |
5.00 | 10496685 |
| MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
3.10 | 16381670 |
| MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
2.93 | 12213967 |
| MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
3.19 | 16810080 |
| MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
5.23 | 11141357 |
| MESH:D009369 |
Neoplasms |
|
Nicotine |
5.23 | 16365874 |
| MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
10.00 | 17289903 |
| MESH:D009389 |
Neovascularization, Pathologic |
|
Nicotine |
10.00 | 16365874 |
| MESH:D009410 |
Nerve Degeneration |
|
Rotenone |
3.79 | 17356569 15790535 18619942 |
| MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
9.11 | 11399458 16427766 |
| MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
9.11 | 14600291 |
| MESH:D019636 |
Neurodegenerative Diseases |
|
Amphetamine |
4.55 | 15183010 |
| MESH:D009765 |
Obesity |
marker/mechanism |
|
| |
| MESH:D009765 |
Obesity |
|
Clozapine |
2.99 | 19142110 18515891 |
| MESH:D010024 |
Osteoporosis |
|
icariin |
4.55 | 19747809 18236786 |
| MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
2.19 | 19401270 |
| MESH:D010146 |
Pain |
|
Morphine |
4.10 | 6776300 20225289 18699797 16273134 15215642 15275824 |
| MESH:D010300 |
Parkinson Disease |
|
Rotenone |
2.94 | 16412576 11535288 19232380 11445065 18619942 15451049 16140633 18191903 19114014 |
| MESH:D020734 |
Parkinsonian Disorders |
|
Rotenone |
3.98 | 18197244 15927086 15574749 15795934 |
| MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.14 | 12520081 |
| MESH:D010538 |
Peritonitis |
|
Ozone |
4.02 | 16369182 |
| MESH:D011014 |
Pneumonia |
|
Lipopolysaccharides |
10.74 | 12224865 11605937 |
| MESH:D011014 |
Pneumonia |
|
Ozone |
10.74 | 18007984 18381685 18929643 |
| MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.45 | 18163543 |
| MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.08 | 11896295 11118676 11399792 11222880 |
| MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
3.78 | 20887781 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
3.14 | 17292933 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
3.14 | 16740699 |
| MESH:D011618 |
Psychotic Disorders |
|
Clozapine |
4.10 | 15331141 |
| MESH:D011629 |
Puberty, Precocious |
|
astressin B |
6.75 | 20002962 |
| MESH:D015427 |
Reperfusion Injury |
|
Morphine |
4.08 | 19211983 |
| MESH:D012120 |
Respiration Disorders |
|
Chlorine |
5.11 | 18579056 |
| MESH:D012130 |
Respiratory Hypersensitivity |
|
Lipopolysaccharides |
3.66 | 10835634 |
| MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.73 | 18990726 |
| MESH:D012559 |
Schizophrenia |
|
Clozapine |
2.72 | 11763009 20452607 20521326 17667964 20580759 17123785 20168265 20521320 18855531 19369910 20107430 18806925 16141801 11151749 17726453 |
| MESH:D012640 |
Seizures |
|
Nicotine |
3.72 | 17873105 |
| MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
5.30 | 10029692 19755658 |
| MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
5.30 | 16192470 |
| MESH:D019956 |
Stereotypic Movement Disorder |
|
Amphetamine |
6.32 | 1977408 |
| MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
1.55 | 2093021 20155912 |
| MESH:D013921 |
Thrombocytopenia |
|
Lipopolysaccharides |
4.07 | 15821434 |
| MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.80 | 12697716 |
| MESH:D013978 |
Tibial Fractures |
|
Estradiol |
4.58 | 19048282 |
| OMIM:188890 |
TOBACCO ADDICTION, SUSCEPTIBILITY TO |
|
Nicotine |
4.65 | 16785264 11259349 16720336 |
| MESH:D014029 |
Tobacco Use Disorder |
|
Nicotine |
5.34 | 15735609 18305452 17979512 18041664 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
2-Naphthylamine |
5.36 | 11144890 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
5.36 | 17053015 |
| MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.49 | 12125929 |
| MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.14 | 15886252 |
| MESH:D015430 |
Weight Gain |
|
Clozapine |
4.37 | 20107430 17502770 20564506 20521320 16402076 16141801 |
| MESH:D015431 |
Weight Loss |
|
Clozapine |
4.97 | 17933447 |